Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No user-facing content or functional changes are evident from the available context.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed, indicating a minor backend version update with no visible changes to the page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedShow glossary and Hide glossary UI options were added, and new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) were introduced. The corresponding older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed or updated.SummaryDifference0.3%

- Check40 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no study content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Beijing Municipality under Locations and updated the location labeling; added Snyder et al. 2014 NEJM citation to Publications, while removing the previous Beijing Municipality Locations entry and its related Erratum citation.SummaryDifference0.3%

- Check90 days agoChange DetectedPublications section updated to clarify that publications are provided voluntarily by contributors who enter information about the study results, and the site revision badges were updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.